Best Practices for Protecting Your IP Overseas

PatentlyBIOJeremy Coombs, MultiLing senior vice president of operations, published an article in BIOtechNOW —  BIO’s blog and show newsletter chronicling “innovations transforming our world” each day of BIO 2014. The article, titled “Protecting Your IP Overseas,” informs readers why working with a partner that employs best practices in people, process and technology is critical when dealing with their company’s most important data. 

According to the World Intellectual Property Organization (WIPO), nearly 100,000 biotechnology and pharmaceutical patent applications are filed worldwide each year. Filing patent applications can be very complex, with different laws, deadlines and languages requiring highly technical translators for most countries in which protection is sought.

bio“By ensuring that your service providers deliver best practices in the areas of people, processes and technology, you will help reduce your risks, increase the value per patent translated and protect your IP throughout the patent filing process – and beyond,” wrote Coombs.

This week in San Diego, MultiLing executives are attending BIO — the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

Read Coombs’ full article here, or visit the MultiLing news room.